PureTech Health (PRTC) Change in Receivables (2024 - 2025)
PureTech Health (PRTC) reported Change in Receivables of $2.5 million for Q2 2025, up 63.34% on a QoQ basis from $1.5 million in Q4 2024.
PureTech Health (PRTC) has 2 years of Change in Receivables data on file, last reported at $2.5 million in Q2 2025.
- Quarterly Change in Receivables changed N/A year-over-year to $2.5 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.5 million (changed N/A YoY) and the FY2025 annual result came in at -$236000.0, down 115.51% from the prior year.
- Change in Receivables climbed to $2.5 million in Q2 2025 per PRTC's latest filing, from $1.5 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.5 million in Q2 2025 and bottomed at $1.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -1.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 110.42 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.49 Mn |
| Jun 30, 2025 | 2.49 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Dec 31, 2024 | 1.52 Mn |